Renaissance Technologies LLC bought a new stake in InspireMD, Inc. (NYSE:NSPR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 10,400 shares of the company’s stock, valued at approximately $27,000.
A number of other large investors have also recently made changes to their positions in the company. Legato Capital Management LLC acquired a new stake in shares of InspireMD during the fourth quarter worth about $47,000. Essex Investment Management Co. LLC acquired a new stake in InspireMD during the 4th quarter worth approximately $191,000. Finally, Affiance Financial LLC grew its stake in shares of InspireMD by 2.9% in the 4th quarter. Affiance Financial LLC now owns 189,122 shares of the company’s stock valued at $497,000 after purchasing an additional 5,376 shares during the last quarter. 44.78% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, StockNews.com initiated coverage on InspireMD in a research note on Monday. They set a “sell” rating for the company.
InspireMD Price Performance
InspireMD stock opened at $2.60 on Friday. The stock’s 50 day moving average price is $2.66 and its 200 day moving average price is $2.74. InspireMD, Inc. has a 1-year low of $2.07 and a 1-year high of $3.80. The company has a market cap of $79.65 million, a PE ratio of -3.47 and a beta of 0.62.
InspireMD Profile
InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.
Featured Stories
- Five stocks we like better than InspireMD
- Market Cap Calculator: How to Calculate Market Cap
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- What Makes a Stock a Good Dividend Stock?
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- Stock Analyst Ratings and Canadian Analyst Ratings
- Is Energy Transfer Undervalued or a Value Trap?
Want to see what other hedge funds are holding NSPR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InspireMD, Inc. (NYSE:NSPR – Free Report).
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
